Bristol-Myers Squibb Co. (BMY) Social Stream



Bristol-Myers Squibb Co. (BMY): $64.44

0.73 (+1.15%)

POWR Rating

Component Grades

Momentum

C

Stability

B

Sentiment

Quality

B

Add BMY to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals

Industry

D

Ranked

#5 of 167

in industry

BRISTOL MYERS SQUIBB CO (BMY) Price Targets From Analysts

Use the tables below to see what analysts covering BRISTOL MYERS SQUIBB CO think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 13 $80 $66 $73.222 $64.56 13.42%
2021-11-17 13 $80 $66 $72.875 $64.56 12.88%
2021-11-18 12 $80 $66 $72.875 $64.56 12.88%
2021-11-19 12 $80 $66 $72.777 $64.56 12.73%
2022-02-07 13 $80 $58 $71.3 $64.56 10.44%
2022-03-25 13 $80 $58 $71.5 $64.56 10.75%
2022-03-30 13 $81 $58 $72.4 $64.56 12.14%
2022-04-18 13 $81 $58 $72.2 $64.56 11.83%
2022-04-22 13 $85 $58 $73.7 $64.56 14.16%
2022-05-02 13 $85 $58 $74.272 $64.56 15.04%
2022-05-16 13 $92 $58 $75.818 $64.56 17.44%
2022-05-25 13 $92 $63 $76.909 $64.56 19.13%
2022-06-01 14 $92 $63 $78 $64.56 20.82%
2022-06-06 14 $92 $63 $78.181 $64.56 21.1%
2022-07-27 15 $92 $63 $78.181 $64.56 21.1%
2022-07-28 17 $92 $61 $79.083 $64.56 22.5%
2022-08-30 17 $92 $61 $78.769 $64.56 22.01%
2022-09-20 17 $94 $61 $79.615 $64.56 23.32%
2022-10-12 18 $94 $61 $79.615 $64.56 23.32%
2022-10-26 18 $94 $60 $79.384 $64.56 22.96%
2022-10-31 18 $94 $60 $79.23 $64.56 22.72%
2022-12-06 16 $94 $60 $79.461 $64.56 23.08%
2023-01-09 17 $94 $60 $80.076 $64.56 24.03%
2023-01-26 18 $95 $60 $81.142 $64.56 25.68%
2023-02-03 18 $95 $60 $81.285 $64.56 25.91%
2023-02-15 18 $95 $62 $81.571 $64.56 26.35%
2023-04-10 19 $95 $62 $80.266 $64.56 24.33%
2023-04-17 19 $94 $62 $79.8 $64.56 23.61%
2023-04-21 19 $94 $62 $79.466 $64.56 23.09%
2023-04-27 19 $94 $62 $79.666 $64.56 23.4%
2023-04-28 19 $94 $59 $79.466 $64.56 23.09%
2023-05-22 19 $94 $59 $79.357 $64.56 22.92%

The Trend in the Analyst Price Target


Over the past 16 months, BMY's average price target has gone up $8.06.

BMY reports an average of 10.92% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-06-06 14 92 63 78.181 75.25 3.9%
2022-10-26 18 94 61 79.461 74.45 6.73%
2023-04-18 19 94 62 79.466 70.23 13.15%
2023-04-21 19 94 62 79.666 70.49 13.02%
2023-05-22 19 94 59 79.357 65.81 20.59%

BMY Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.23 8 0 10 1 1 19

The Trend in the Broker Recommendations


BMY's average broker recommendation rating worsened by 0.52 over the prior 30 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, BRISTOL MYERS SQUIBB CO's number of analysts covering the stock is higher than 3190.94% of them.
  • In the context of Pharmaceutical Products stocks, BRISTOL MYERS SQUIBB CO's upside potential (average analyst target price relative to current price) is greater than 663.14% of them.
  • BMY has a greater average analyst price target than 3085.36% of Pharmaceutical Products stocks.
  • BRISTOL MYERS SQUIBB CO's variance in analysts' estimates is lower than -777.58% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to BRISTOL MYERS SQUIBB CO are LEGN, RPRX, and CVAC.

Make investment decisions regarding BMY using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7833 seconds.